Evidence map›Paper›PMID 41519990›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Prevalence of statin utilization in cancer survivors in a family medicine clinic.

Raechel T White, Cyrille K Cornelio, Athanasios Tsalatsanis, Karim Hanna, Jay Sharad Maru, Emily Vial, Nicholas W Carris

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raechel T WhiteUSF Health Taneja College of Pharmacy, University of South Florida, 560 Channelside Dr., Tampa, FL, 33602, USA.ORCID http://orcid.org/0000-0002-5929-5590
Cyrille K CornelioUSF Health Taneja College of Pharmacy, University of South Florida, 560 Channelside Dr., Tampa, FL, 33602, USA. ccornelio@usf.edu.ORCID http://orcid.org/0000-0003-0499-675X
Athanasios TsalatsanisResearch Methodology and Biostatistics Core, USF Health Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd, Tampa, FL, 33612, USA.ORCID http://orcid.org/0000-0003-3818-8283
Karim HannaUSF Health Morsani College of Medicine, University of South Florida, 560 Channelside Dr., Tampa, FL, 33602, USA.ORCID http://orcid.org/0000-0002-2194-8875
Jay Sharad MaruResearch Methodology and Biostatistics Core, USF Health Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd, Tampa, FL, 33612, USA.
Emily VialUSF Health Taneja College of Pharmacy, University of South Florida, 560 Channelside Dr., Tampa, FL, 33602, USA.
Nicholas W CarrisUSF Health Taneja College of Pharmacy, University of South Florida, 560 Channelside Dr., Tampa, FL, 33602, USA. Carris@usf.edu.ORCID http://orcid.org/0000-0001-8904-5034

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs people live longer after a cancer diagnosis, there is an increasing need to focus on chronic disease state management in the primary care setting. Particular attention to appropriate statin prescribing in cancer survivors is warranted given a heightened risk of atherosclerotic cardiovascular disease (ASCVD). The purpose of this study was to further understand cardiovascular care in cancer survivors by identifying the proportion of cancer survivors with a prescription for appropriate statin therapy and to identify associated factors.

methodsA retrospective cohort study was conducted to identify cancer survivors aged 40-75 years with a diagnosis of breast, lung, colorectal, or lymphatic and hematopoietic cancers cared for within family medicine clinics in a large academic health system. Statin prescriptions were assessed to identify the percentage of statin candidates prescribed a statin based on a diagnosis of ASCVD or type 2 diabetes.

resultsData from 8763 cancer survivors were included in the final analysis. Among patients with ASCVD, 66% were prescribed a statin. In patients with type 2 diabetes without ASCVD, 58% were prescribed a statin. Female sex was negatively associated with statin prescribing (OR 0.88, 95% CI 0.80-0.97).

conclusionsStatins are underutilized in cancer survivors, as they are in the general population. This may present an area of health disparity given the heightened risk of ASCVD in cancer survivors. Cancer survivors suffer from a heightened risk of death from CVD. As survivors enjoy longer lifespans after diagnosis, there is a need to optimize cardiometabolic disease state management in this high-risk population.

Indexed as

Cancer SurvivorsCardiovascular DiseasesHydroxymethylglutaryl-CoA Reductase InhibitorsNeoplasmsPractice Patterns, Physicians'AdultAgedAtherosclerosisDiabetes Mellitus, Type 2Family PracticeFemaleHumansMaleMiddle AgedRetrospective StudiesSex FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsCancer survivorsCardio-oncologyCardiovascular diseasesHydroxymethylglutaryl-CoA reductase inhibitors

Identifiers

PMID41519990

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.